Endocrinology News

Historically, much of the medical conversation around polycystic ovary syndrome, which affects 5% to 20% of women worldwide, has centered on fertility, but the condition extends far beyond reproductive health.

Decreases in body weight and HbA1c induced by GLP-1 receptor agonists and other diabetes drugs can reduce the risk for cardiometabolic complications for adults newly diagnosed with type 2 diabetes, researchers reported.

A quarter of adults would consider using an injectable weight loss drug without consulting a health care provider, according to the results of a survey from The Ohio State University Wexner Medical Center.

A county-level assessment of deaths from cardio-kidney-metabolic disease and social determinants of health revealed that particular determinants are more or less important in different U.S. regions, researchers reported in JAMA.

Hormone therapy use markedly declined among postmenopausal women of all ages, races and ethnicities in the U.S. during the past 2 decades, according to findings published in JAMA Health Forum.

The FDA has lifted a clinical hold on two trials assessing an investigational treatment for people with type 1 and type 2 diabetes, Biomea Fusion announced.

A recently proposed U.S. Senate bill aims to crack down on social media influencers and others online who make misleading comments about pharmaceutical drugs.

Adults diagnosed with endogenous Cushing’s syndrome have a higher risk for developing cancer compared with controls without the condition, according to data published in the European Journal of Endocrinology.

Replacing ultraprocessed foods with lesser or nonprocessed options may decrease the risk of developing type 2 diabetes, results from a prospective cohort analysis in the Lancet Regional Health Europe showed.

In patients with persistent chylomicronemia, plozasiran, a small interfering RNA therapy, was associated with lower triglyceride levels and reduced risk for pancreatitis, researchers reported at the European Society of Cardiology Congress.